nedaplatin has been researched along with Colonic Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furutani, K; Fuwa, N; Ito, Y; Kamata, M; Kodaira, T; Matsumoto, A; Tachibana, H | 1 |
| Isono, K; Kakegawa, T; Kurihara, M; Nabeya, K; Ota, K; Taguchi, T; Wakui, A | 1 |
| Ariyoshi, Y; Inuyama, Y; Kimura, I; Majima, H; Niitani, H; Ogawa, M; Ota, K; Taguchi, T; Wakui, A; Yoshida, O | 1 |
2 trial(s) available for nedaplatin and Colonic Neoplasms
| Article | Year |
|---|---|
Phase I study of combination chemotherapy with 5-fluorouracil (5-FU) and nedaplatin (NDP): adverse effects and eecommended dose of NDP administered after 5-FU.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Drug Administration Schedule; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Remission Induction; Uterine Cervical Neoplasms | 2002 |
[A phase II clinical study of cis-diammine glycolato platinum, 254-S, for gastrointestinal cancers. 254-S Gastrointestinal Cancer Study Group].
Topics: Antineoplastic Agents; Colonic Neoplasms; Drug Administration Schedule; Drug Evaluation; Esophageal Neoplasms; Humans; Infusions, Intravenous; Leukopenia; Middle Aged; Nausea; Organoplatinum Compounds; Stomach Neoplasms; Thrombocytopenia | 1992 |
1 other study(ies) available for nedaplatin and Colonic Neoplasms
| Article | Year |
|---|---|
[Phase I study of a new platinum complex 254-S, cis-diammine (glycolato)-platinum (II)].
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Colonic Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infusions, Intravenous; Kidney; Lung Neoplasms; Male; Middle Aged; Neoplasms; Organoplatinum Compounds; Prostatic Neoplasms | 1992 |